- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sichuan Kelun Biotech (6990)
Sichuan Kelun Biotech stock price live, this page displays HK 6990 stock exchange data. View the 6990 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sichuan Kelun Biotech real time stock price chart below.
What Is the Sichuan Kelun Biotech Stock Price Today?
The Sichuan Kelun Biotech stock price today is 450.20.
What Is the Stock Symbol for Sichuan Kelun Biotech?
The stock symbol for Sichuan Kelun Biotech is ""6990.""
What Stock Exchange Does Sichuan Kelun Biotech Trade On?
Sichuan Kelun Biotech is listed and trades on the Hong Kong stock exchange.
Is Sichuan Kelun Biotech a Good Stock to Buy?
Determining whether Sichuan Kelun Biotech—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6990 quote. (ISIN: CNE1000062J1)
What Is the Sichuan Kelun Biotech Stock Price Today?
The Sichuan Kelun Biotech stock price today is 450.20.
What Is the Stock Symbol for Sichuan Kelun Biotech?
The stock symbol for Sichuan Kelun Biotech is ""6990.""
What Stock Exchange Does Sichuan Kelun Biotech Trade On?
Sichuan Kelun Biotech is listed and trades on the Hong Kong stock exchange.
Is Sichuan Kelun Biotech a Good Stock to Buy?
Determining whether Sichuan Kelun Biotech—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6990 quote. (ISIN: CNE1000062J1)
Hong Kong
Currency in HKD
450.20
-35.40(-7.29%)
Delayed Data·
Fair Value
An estimate of a Sichuan Kelun Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
443.00
498.00
52 wk Range
152.00
498.00
6990 Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
1/2
Fair Value
An estimate of a Sichuan Kelun Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
443.00498.00
52 wk Range
152.00498.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6990 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sichuan Kelun Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
475.96
Upside
+5.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Sichuan Kelun Biotech Company Profile
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally. Its product pipeline includes Sac-TMT, a novel TROP2 ADC positioned as a monotherapy and part of combination therapies for treating various advanced solid tumors; Trastuzumab botidotin, a monotherapy to treat advanced HER2+ solid tumors; SKB315, a novel CLDN18.2 ADC targeting advanced solid tumors; SKB410/MK-3120, a novel Nectin-4 ADC targeting advanced solid tumors; and SKB571/MK-2750, a novel bsADC primarily targeting various solid tumors, such as LC and CRC. The company also develops SKB518, SKB535/MK-6204 and SKB445, which are novel ADC drugs with potential FIC targets; SKB500 and SKB501, which are novel ADC drugs with verified targets but differentiated payload-linker strategies; SKB107, an RDC targeting tumor bone metastases; Tagitanlimab, PD-L1 mAb for its immunotherapy franchise; Cetuximab N01, a recombinant EGFR human-mouse chimeric mAb; A400, a novel selective RET inhibitor; and A296, a novel small molecule STING agonist. It has license and collaboration arrangements with Merck Sharp & Dohme LLC; Harbour BioMed Therapeutics Limited; Windward Bio AG; and Ellipses Pharma Limited. The company was incorporated in 2016 and is headquartered in Chengdu, the People’s Republic of China. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.
Compare 6990 to Peers and Sector
Metrics to compare | 6990 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6990PeersSector | |
|---|---|---|---|---|
P/E Ratio | −141.0x | −20.7x | −0.5x | |
PEG Ratio | 0.49 | 0.31 | 0.00 | |
Price/Book | 20.3x | 6.9x | 2.6x | |
Price / LTM Sales | 67.8x | 23.2x | 3.3x | |
Upside (Analyst Target) | 7.5% | −13.4% | 38.7% | |
Fair Value Upside | Unlock | −13.1% | 5.0% | Unlock |
Analyst Ratings
17 Buy
1 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 475.96
(+5.72% Upside)
Earnings
Latest Release
Aug 18, 2025
EPS / Forecast
-0.64 / -1.17
Revenue / Forecast
950.45M / --
FAQ
What Stock Exchange Does Sichuan Kelun Biotech Trade On?
Sichuan Kelun Biotech is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Sichuan Kelun Biotech?
The stock symbol for Sichuan Kelun Biotech is "6990."
What Is the Sichuan Kelun Biotech Market Cap?
As of today, Sichuan Kelun Biotech market cap is 99.19B.
What Is Sichuan Kelun Biotech's Earnings Per Share (TTM)?
The Sichuan Kelun Biotech EPS (TTM) is -3.20.
From a Technical Analysis Perspective, Is 6990 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sichuan Kelun Biotech Stock Split?
Sichuan Kelun Biotech has split 0 times.
How Many Employees Does Sichuan Kelun Biotech Have?
Sichuan Kelun Biotech has 1870 employees.
What is the current trading status of Sichuan Kelun Biotech (6990)?
As of 27 Aug 2025, Sichuan Kelun Biotech (6990) is trading at a price of 450.20, with a previous close of 485.60. The stock has fluctuated within a day range of 443.00 to 498.00, while its 52-week range spans from 152.00 to 498.00.
What Is Sichuan Kelun Biotech (6990) Price Target According to Analysts?
The average 12-month price target for Sichuan Kelun Biotech is HKD475.95569, with a high estimate of HKD560 and a low estimate of HKD297.2. 17 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an +5.72% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.